Please use this identifier to cite or link to this item:
Title: Indirect costs associated with skin infectious disease in children: a systematic review
Author: Lizano Díez, Irene
Naharro, Jesús
Zsolt, Ilonka
Keywords: Malalties de la pell
Infants malalts
Cost de l'assistència sanitària
Skin diseases
Sick children
Cost of medical care
Issue Date: 1-Dec-2021
Publisher: BioMed Central
Abstract: Background: There are limited data in the literature on the indirect costs associated with skin and soft tissue infections (SSTIs) in the pediatric population. This study aimed to conduct a systematic review of the indirect costs associated with SSTIs in children. Methods: The search was conducted in PubMed, SCOPUS, and Web of Science up to January 2020. Thirteen search strategies were designed combining MeSH terms and free terms. SSTIs were defined as bacterial or viral infections, dermatomycoses, and parasitic infestations. Only primary studies were included. All analyzed costs were converted to 2020 Euros. Results: Thirteen of the identified publications presented indirect costs of SSTIs in children and were conducted in Argentina, Australia, Brazil, Hungary, New Zealand, Poland, Spain, Taiwan, and the USA. Nine studies described indirect costs associated with infection of Varicella-zoster virus: lost workdays by outpatient caregivers ranged from 0.27 to 7.8, and up to 6.14 if caring for inpatients; total productivity losses ranged from 1.16 to 257.46 per patient. Three studies reported indirect costs associated with acute bacterial SSTIs (community-associated methicillinresistant Staphylococcus aureus) in children: total productivity losses ranged from 1,814.39 to 8,224.06 per patient, based on impetigo, cellulitis, and folliculitis. One study of parasitic infestations (Pediculus humanus capitis) reported total indirect costs per patient of 68.57 (formal care) plus 21.41 due to time lost by parents in purchasing treatment. Conclusions: The economic burden of SSTIs is highly relevant but underestimated due to the lack of studies reporting indirect costs. Further cost studies will allow a better understanding of the magnitude of the financial burden of the disease. Keywords: Skin infectious diseases, Cost of illness, Indirect costs, Child, SSTIs, Systematic review
Note: Reproducció del document publicat a:
It is part of: BMC Health Services Research, 2021, vol. 21, num. 2021, p. 1325
Related resource:
ISSN: 1472-6963
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
720591.pdf771.21 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons